If its painful, spreading, interfering with sleep, or getting worse after a dose increase, its worth asking whether staying at your current dose, lowering the dose, or pausing treatment makes sense
Constipation becomes the dominant side effect for many patients after nausea subsides
November 14th, 2025: Three New Jersey Cases Added to Expanding GLP-1 Drug MDL A federal judicial panel has transferred three additional lawsuits from New Jersey into the growing multidistrict litigation involving claims that Eli Lilly and Novo Nordisk minimized the safety risks associated with GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and Trulicity
(b) TIR efficacy in neuroprotection
Many human diseases are accompanied by low blood and tissue levels of selenium, and increased dietary selenium enhances selenium concentrations throughout the body [58]